GLP-1 Medications for Weight Loss: A Patient's Guide to Wegovy & Zepbound

GLP-1 medications — Wegovy, Zepbound, Ozempic, Mounjaro — are the most significant change in weight medicine in a generation. They also come with more hype than almost any drug in recent memory, which makes it harder for patients to figure out what's real, what's marketing, and what's actually right for them. This guide is the version of the conversation I have with patients in the office, written out.

What GLP-1 medications actually are

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases when you eat. Among other things, GLP-1 tells your pancreas to release insulin, slows down how fast your stomach empties, and signals to your brain that you're full. People who struggle with weight often have a blunted GLP-1 response — their body doesn't send the "I've eaten enough" signal as strongly.

GLP-1 receptor agonists are drugs that mimic this hormone, but with a much longer-lasting effect. Instead of the brief signal you'd get from a meal, the medication holds the satiety signal on for days at a time. The result: most people feel less hungry, eat smaller portions naturally, and stop thinking about food constantly.

The main options

• Wegovy — semaglutide, once-weekly injection, FDA-approved specifically for chronic weight management
• Zepbound — tirzepatide, once-weekly injection, FDA-approved for chronic weight management; acts on two hormones (GLP-1 and GIP), and tends to produce slightly more weight loss in head-to-head studies
• Ozempic / Mounjaro — same active ingredients as Wegovy and Zepbound, but FDA-approved for type 2 diabetes rather than weight loss. Sometimes prescribed off-label for weight when insurance won't cover the weight-loss versions.

What kind of weight loss is realistic

In the major clinical trials:

• Patients on semaglutide (Wegovy) lost an average of about 15% of their body weight over 68 weeks
• Patients on tirzepatide (Zepbound) lost an average of about 20% over 72 weeks at the highest dose

For someone who weighs 220 pounds, that's roughly 33 to 44 pounds. Individual results vary widely — some patients lose more, some less, and a small minority don't respond meaningfully at all. The goal isn't a number on a scale; it's a sustainable change in how your body relates to food.

Who qualifies (clinically)

FDA labeling for the weight-loss versions is generally:

• BMI of 30 or higher, or
• BMI of 27 or higher with at least one weight-related condition (type 2 diabetes, hypertension, sleep apnea, high cholesterol, fatty liver, etc.)

Insurance coverage is more restrictive than FDA labeling — some plans require documented attempts at lifestyle changes, evidence of comorbidities, or prior authorization paperwork. We handle that paperwork as part of the visit; you don't need to figure it out yourself.

Side effects — the honest version

Most side effects involve the gut, because that's where the medication does much of its work:

• Nausea — by far the most common, especially in the first few weeks and after dose increases
• Reduced appetite — usually the desired effect, but occasionally so strong that people forget to eat enough
• Constipation or, less commonly, diarrhea
• Fatigue, especially in the first month
• "GLP-1 face" — the popular term for the way rapid weight loss can leave the face looking thinner or older. This isn't a drug effect; it's what happens with any rapid weight loss. Slower titration tends to produce a more gradual change.

Rare but serious side effects include pancreatitis, gallbladder problems, and (in animals) certain thyroid tumors. People with a personal or family history of medullary thyroid cancer or MEN-2 syndrome should not take these medications. We screen for these at the first visit.

What the program actually looks like at our office

This isn't a med-spa "pill mill" experience. It's primary care medicine.

1. Visit 1 — workup. Comprehensive medical history, vital signs, focused exam, baseline labs (including A1c, lipid panel, liver function, kidney function, thyroid), and a real conversation about your goals and history. We screen for the conditions that make GLP-1 use unsafe.
2. Visit 2 — start. If labs and history look right, we prescribe a starting dose. Insurance prior authorization happens here if needed.
3. Follow-up — every 4 weeks at first. We track weight, side effects, blood pressure, and whether the dose needs to increase. Most patients reach a maintenance dose within 4–5 months.
4. Long-term — every 2–3 months. Periodic labs, nutrition check-ins, and adjustments. Weight medicine is chronic medicine — most people who do well on these drugs and stop them regain weight, so the long-term plan matters.

Cost and insurance

Cost is the single biggest barrier. Cash price for brand-name Wegovy or Zepbound runs around $1,000–$1,300 per month. Insurance coverage is improving but still inconsistent — Medicare currently does not cover GLP-1s for weight loss alone, while many commercial plans do, often with prior authorization.

Practical paths we use with patients:

• Check coverage and pursue prior authorization through your plan
• Manufacturer savings programs (Novo Nordisk and Eli Lilly both offer them) when commercially insured
• Direct-purchase options from the manufacturer at reduced cash prices for self-pay patients
• If diabetes is on the table, an Ozempic or Mounjaro prescription on the diabetes side

We'll be honest with you about cost up front. There's no benefit to starting a medication you can't afford to continue.

The thing nobody talks about

GLP-1s work better paired with realistic protein intake, basic resistance exercise, and a sleep routine — not because diet and exercise "should be enough on their own" (that's the old, often unkind framing), but because muscle mass and metabolism matter, and rapid weight loss without strength training tends to lose more muscle than ideal. The conversation we have in the office covers this, not just the prescription.

Is this the right medication for you?

The honest answer is: it depends on your medical history, your insurance, your goals, and how your body responds. The only way to know is a real evaluation. If you're curious, the first step is a single visit. No commitment, no judgment.

About this article: Published by Ridgewood Primary Care. The information here is general patient education, not personalized medical advice. GLP-1 medications carry real risks and are not appropriate for everyone — individual treatment decisions should always be made with a qualified physician after a complete medical evaluation. In a medical emergency, call 911.